Skip to main content
68th Annual Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Red Recording
Red Recording
Sig Meeting
Sig Meeting

Therapeutics (NON-Industry)

(T 41) Efficacy of Ubrogepant 100 mg Based on Prior Triptan Experience: Results From the ACHIEVE I Study

    Non-presenting Author(s)

  • Andrew M. Blumenfeld, MD

    Faculty neurologist
    Cedars Sinai
    Los Angeles, California, United States

  • Peter Goadsby, PhD DSc FRACP FRCP FMedSci FRS

    Professor of Neurology and Honorary Consultant Neurologist
    University of Leeds UK, King Abdullah University of Science and Technology, Saudi Arabia,NIHR King’s Clinical Research Facility, & SLaM Biomedical Research Centre, and The Wolfson Sensory, Pain and Regeneration Centre (SPaRC), Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
    London, United Kingdom

  • Susan Hutchinson, MD

    Director-Headache Medicine
    Haven Headache & Migraine Center, SF, CA, USA
    Laguna Hills, California, United States

  • David W. Dodick, MD, FAAN

    Professor (Emeritus)
    Mayo Clinic, Phoenix, AZ, USA
    New York, New York, United States

  • Cynthia E. Armand, MD

    Assistant Professor of Neurology
    Department of Neurology and Headache Center, Albert Einstein College of Medicine, Bronx, NY, USA
    Bronx, New York, United States

    • Presenting Author(s)

  • NC

    Natty Chalermpalanupap, PhD

    AbbVie Inc., North Chicago, IL, USA
    Chicago, Illinois, United States

    • Non-presenting Author(s)

  • CW

    Cuiwei Wang, MS

    AbbVie Inc., North Chicago, IL, USA
    North Chicago, Illinois, United States

  • EB

    Elimor Brand-Schieber, PhD, MS

    AbbVie Inc., North Chicago, IL, USA
    North Chicago, Illinois, United States

  • Umer Najib, MD

    Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, USA
    Morgantown, West Virginia, United States